Silex Systems (SILXY) ADR EACH 5 ORD SHS NPV LVL1 SPN (BNY)

Sell:$19.00Buy:$19.00No change

Prices delayed by at least 15 minutes
Sell:$19.00
Buy:$19.00
Change:No change
Prices delayed by at least 15 minutes
Sell:$19.00
Buy:$19.00
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Silex Systems Limited is a technology commercialization company. The Company is focused on the commercialization of its Separation of Isotopes by Laser EXcitation (SILEX) laser enrichment technology for application to uranium production and enrichment (nuclear power), silicon enrichment (silicon quantum computing) and medical isotope enrichment (new cancer therapies). Its segments include Silex Systems, Translucent and Silex USA. Silex Systems is based in New South Wales and Translucent and Silex USA are based in North Carolina. The SILEX technology has been under development for uranium enrichment jointly with exclusive licensee Global Laser Enrichment LLC. It is also focused on the development of additional commercial applications of the SILEX technology, including the production of Zero-Spin Silicon for the emerging technology of silicon-based quantum computing. It has an interest in a semiconductor technology known as cREO through its ownership of subsidiary Translucent Inc.

Key people

Michael P. Goldsworthy
Chief Executive Officer, Managing Director, Executive Director
Julie E. Russell
Chief Financial Officer, Company Secretary
Craig Andrew Roy
Non-Executive Independent Chairman of the Board
Susan Jane Corlett
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Australia
  • Sector
    Technology
  • Industry
    Semiconductors
  • ISIN
    US8270461036
  • Market cap
    $873.20m
  • Employees
    38
  • Shares in issue
    236.88m
  • Exchange
    Australian Stock Exchange Ltd
  • Index
    ASX All Ordinaries Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.